A61P 5/06
Drugs for disorders of the endocrine system: of the anterior pituitary hormones
Official title: of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
A61P5/06 (Drugs for disorders of the endocrine system: of the anterior pituitary hormones) appears on 1,078 US grants and 1,558 published applications in this corpus.
Search patents in A61P- Granted patents
- 1,078
- Published applications
- 1,558
- Assignees
- 595
- Inventors
- 2,508
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 9 | 0 |
| 1998 | 13 | 0 |
| 1999 | 20 | 0 |
| 2000 | 26 | 0 |
| 2001 | 27 | 7 |
| 2002 | 29 | 40 |
| 2003 | 34 | 61 |
| 2004 | 27 | 91 |
| 2005 | 26 | 67 |
| 2006 | 33 | 92 |
| 2007 | 42 | 85 |
| 2008 | 45 | 105 |
| 2009 | 36 | 97 |
| 2010 | 52 | 93 |
| 2011 | 63 | 92 |
| 2012 | 75 | 77 |
| 2013 | 79 | 61 |
| 2014 | 63 | 83 |
| 2015 | 53 | 53 |
| 2016 | 51 | 77 |
| 2017 | 47 | 65 |
| 2018 | 39 | 52 |
| 2019 | 40 | 42 |
| 2020 | 32 | 46 |
| 2021 | 27 | 35 |
| 2022 | 21 | 47 |
| 2023 | 17 | 18 |
| 2024 | 15 | 26 |
| 2025 | 17 | 29 |
| 2026 | 11 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Non-surgical prevention of unpleasant odor in meats and aggressive or sexual behavior in male ruminants28 Jul 2026US 12,691,126 B2Insigna Inc.
- Fc region variant2 Jun 2026US 12,643,937 B2Chugai Seiyaku Kabushiki Kaisha
- Proliposomal testosterone undecanoate formulations19 May 2026US 12,629,381 B2
- Concomitant administration of glucocorticoid receptor modulator relacorilant and CYP2C9 substrates5 May 2026US 12,616,685 B2Corcept Therapeutics, Inc.
- Specification of functional cranial placode derivatives from human pluripotent stem cells5 May 2026US 12,618,044 B2Memorial Sloan Kettering Cancer Center
- Compositions and methods for the treatment of congenital adrenal hyperplasia8 Oct 2026US 2026/0306485 A1Crinetics Pharmaceuticals, Inc.
- Dissolvable microneedle patch for large molecule therapeutic delivery17 Sep 2026US 2026/0273253 A1Maman Biomedical Inc.
- Methods for treating testicular and ovarian adrenal rest tumors27 Aug 2026US 2026/0248795 A1Spruce Biosciences, Inc.
- Methods for treating testicular and ovarian adrenal rest tumors27 Aug 2026US 2026/0248796 A1Spruce Biosciences, Inc.
- Methods for treating testicular and ovarian adrenal rest tumors27 Aug 2026US 2026/0248797 A1Spruce Biosciences, Inc.
Most cited
By later US patents
- 3-heteroaryl-2-indolinone compounds for the treatment of disease265US 5,792,783 ASugen, Inc. · 1998
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- 3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease169US 5,883,113 ASugen, Inc. · 1999
- 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease168US 5,886,020 ASugen, Inc. · 1999
- 3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease165US 5,834,504 ASugen, Inc. · 1998